Decreased Supplement Use For Weight Loss Possible OTC Orlistat Benefit

Decreased use of dietary supplements for weight loss was perceived as a significant public health benefit by FDA advisory committee members reviewing the Rx-to-OTC switch application for GlaxoSmithKline's Alli (orlistat 60 mg)

More from Archive

More from Pink Sheet